Abstract:xCT is a sodium-independent amino acid antiporter that imports L-cystine and exports L-glutamate in a 1:1 ratio. It is a component of heterodimeric amino acid transporter system Xc- working at the cross-roads of maintaining neurological processes and regulating antioxidant defense. The transporter has 12 transmembrane domains with intracellular N- and C-termini, and like other transporter proteins can undergo various conformational changes while switching the ligand accessibilities from intracellular to extracellular site. In the present study, we generated two homology models of human xCT in two distinct conformations: inward-facing occluded state and outward-facing open state. Our results indicated the substrate translocation channel composed of transmembrane helices TMs 1, 3, 6, 8, and 10. We docked anionic L-cystine and L-glutamate within the cavities to assess the two distinct binding scenarios for xCT as antiporter. We also assessed the interactions between the ligands and transporter and observed that ligands bind to similar residues within the channel. Using MM-PBSA/MM-GBSA approach, we computed the binding energies of these ligands to different conformational states. Cystine and glutamate bind xCT with favorable binding energies, with more favorable binding observed in inward occluded state than in outward open state. We further computed the residue-wise decomposition of these binding energies and identified the residues as essential for substrate binding/permeation. Filtering the residues that form favorable energetic contributions to the ligand binding in both the states, our studies suggest T56, A60, R135, A138, V141, Y244, A247, F250, S330, L392, and R396 as critical residues for ligand binding as well as ligand transport for any conformational state adopted by xCT during its transport cycle..Graphical

Reanalysis of Structure/function Correlations in the Region of Transmembrane Segments 4 and 5 of the Rabbit Sodium/glucose Cotransporter.

Transmembrane IV of the high-affinity sodium-glucose cotransporter participates in sugar binding.

THE STRUCTURAL AND FUNCTIONAL IMPORTANCE OF TYPE II DIVERGENT AMINO ACIDS IN THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Effects on Conformational States of the Rabbit Sodium/glucose Cotransporter Through Modulation of Polarity and Charge at Glutamine 457.

Structures of Human SGLT in the Occluded State Reveal Conformational Changes During Sugar Transport

Identification of a Disulfide Bridge in Sodium-Coupled Neutral Amino Acid Transporter 2(SNAT2) by Chemical Modification

Structural Basis for the Reaction Cycle and Transport Mechanism of Human Na + -Sulfate Cotransporter NaS1 (SLC13A1)

Substituted-cysteine accessibility and cross-linking identify an exofacial cleft in the 7th and 8th helices of the proton-coupled folate transporter (SLC46A1)

Cross-Linking and Functional Analyses for Dimerization of a Cysteine Mutant of Glycine Transporter 1

In silico characterization of residues essential for substrate binding of human cystine transporter, xCT

Structural Insights into the Gating Mechanism of Human SLC26A9 Mediated by Its C-terminal Sequence

Crystal Structure of a Bacterial Homologue of Glucose Transporters GLUT1–4

Biochemical characterization of a GDP-mannose transporter from Chaetomium thermophilum

In silico structural studies on the vesicular neutral amino acid transporter NTT4 (SLC6A17)

Structure/functional aspects of the human riboflavin transporter-3 (SLC52A3): role of the predicted glycosylation and substrate-interacting sites

Structural Mechanism of SGLT1 Inhibitors

Structure and function analysis of the C. elegans aminophospholipid translocase TAT-1.

Expression, Purification, and Structural Insights for the Human Uric Acid Transporter, GLUT9, Using the Xenopus laevis Oocytes System

Mechanism Of Sulfate Selectivity And Transport In A Slc26 Family Of Sulfate Transporter

Crucial effects of amino acid side chain length in transmembrane segment 5 on substrate affinity in yeast glucose transporter Hxt7.

Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4)